DAVID EICHENBAUM, M.D.
Ophthalmology Physician · ST PETERSBURG, FL
Individual Active NPI 1144251356
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 902 | 94,790 | $12,456,982 | $4,432,051 | $3,504,009 |
| 2023 | 908 | 50,364 | $11,690,761 | $4,230,901 | $3,332,095 |
| 2022 | 935 | 20,624 | $11,086,766 | $4,119,075 | $3,241,151 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 47,820 | $34 | $27 |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 31,200 | $1 | $1 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 3,345 | $146 | $116 |
| 92134 | Imaging of retina | 1,966 | $40 | $30 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,720 | $328 | $262 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,720 | $109 | $87 |
| 67028 | Injection of drug into eye | 1,524 | $133 | $101 |
| 92014 | Established patient complete exam of visual system | 779 | $126 | $92 |
| J0178 | Injection, aflibercept, 1 mg | 682 | $832 | $661 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 470 | $229 | $182 |
| 92250 | Photography of the retina | 412 | $37 | $28 |
| 92012 | Established patient problem focused exam of visual system | 395 | $89 | $68 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | ME90466 | FL |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ME90466 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Florida
- NPI 1467450791
- NPI 1093385452
- NPI 1427238211
- NPI 1841391661
- NPI 1487756318
- NPI 1043202583
- NPI 1215964697
- NPI 1992726657
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.